Mielodiszplasztikus szindróma (MDS): vizsgálatok itt: Svédország
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 17.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Where
- Gothenburg, Huddinge, Lund, Örebro
- Életkor
- 18 év and over
- People
- 225 worldwide
- Run by
- Takeda
See details and how to joinNCT06499285 · EU 2024-516009-22-00 - 3. fázisTaking peopleLisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
- Where
- Örebro
- Életkor
- 18 év and over
- People
- 490 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06641414 · EU 2024-517247-31-00 - 3. fázisBefejeződöttA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Gothenburg, Lund, Stockholm
- Életkor
- 18 év and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060 - 1/2. fázisBefejeződöttStudy to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Where
- Stockholm
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- CellCentric Ltd.
See details and how to joinNCT04068597 - 2. fázisTaking peopleNMDSG-14B2
- Where
- Goteborg, Huddinge, Linkoping, Lund, Umeå, Uppsala
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Karolinska University Hospital
See details and how to join2024-511651-17-00 - 1/2. fázisBefejeződöttClinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Huddinge
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Aptose Biosciences Inc.
See details and how to joinNCT03850574 · EU 2023-503244-14-00 - 2. fázisTaking peopleVaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
- Where
- Gothenburg, Linköping, Lund, Stockholm, Uppsala
- Életkor
- 18 év to 45 év
- People
- 100
- Run by
- Vastra Gotaland Region
See details and how to joinNCT06793410 - 2. fázisTaking peopleCombining Active and Passive DNA Hypomethylation
- Where
- Gothenburg, Lund, Stockholm, Uppsala
- Életkor
- 18 év and over
- People
- 196 worldwide
- Run by
- Kirsten Grønbæk
See details and how to joinNCT03999723 - 2. fázisTaking peopleA Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS
- Where
- Stockholm
- Életkor
- 18 év and over
- People
- 200
- Run by
- Karolinska University Hospital
See details and how to joinNCT05788679